Today, WHO announces it is the first of the United Nations agencies to join a coalition of research funders and charitable foundations (cOAlition S), an initiative to make full and immediate open access to research publications a reality

Quick Read

“Polypills” of generic drugs may dramatically reduce heart attacks and strokes in poor countries, a new study suggests. Some experts still aren’t enthusiastic

Quick Read

Global survey finds that unclear publishing policies place an additional burden on many scientists who don’t speak English as a first language

Quick Read

The pharmaceutical giant Merck & Co. Inc. is ending a long-term agreement to supply a lifesaving vaccine for children in West Africa. At the same time, the company has started sending the vaccine to China, where it will likely be sold for a much higher price

Quick Read

The Trump administration has announced further cuts in aid to the Palestinians — this time, cutting money to cover cancer treatments and other critical care for Palestinians at Jerusalem hospitals

Quick Read

A 60-year-old antifungal drug called flucytosine that should cost a few dollars a day but is now vastly more expensive than that

Quick Read

There are now several experimental treatments vying to be tested, but each must be greenlit by national regulatory authorities whenever and wherever an outbreak occurs. There remain deeply divergent positions among scientists about how to design outbreak trials, specifically whether studies that don’t compare treatments to placebos can generate useful data

Quick Read

The infection, an emerging threat, has killed virtually all of its victims so far in India

Quick Read